A2 Milk Company share price on watch after strong trading update

The A2 Milk Company Ltd (ASX:A2M) share price could be on the move today after a strong trading update at its annual general meeting…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The A2 Milk Company Ltd (ASX: A2M) share price could be on the move on Tuesday after the infant formula and fresh milk company provided a trading update ahead of annual general meeting.

a woman

How has a2 Milk Company performed in FY 2020?

The fast-growing company has continued its positive form during FY 2020.

CEO Jayne Hrdlicka revealed that she expects a2 Milk to deliver revenue in the range of NZ$780 million to NZ$800 million during the first half of the financial year. This compares to NZ$613.1 million in the prior corresponding period. Which implies year on year growth of 27.2% to 30.5%.

Once again, the China market is the key driver of this growth. China label infant nutrition sales are forecast to be approximately NZ$135 million, representing a growth rate of ~84%. CBEC infant nutrition sales are forecast to be approximately NZ$155 million, representing a growth rate of ~54%

The company's ANZ English label infant nutrition sales are growing, but at a much slower rate. These sales are forecast to be approximately NZ$350 million, which represents a growth rate of ~9%.

Also supporting its growth is its Fresh Milk business. Fresh Milk sales in the United States are expected to more than double to NZ$27 million. Whereas Australian fresh milk sales are forecast to come in at NZ$75 million, representing a growth rate of ~12%.

Margins.

There have been a lot of concerns over a2 Milk's margins due to its increased spend on sales and marketing activities.

The good news is that margins are anticipated to be better than expected. In the first half its EBITDA margin is expected to be in the range of 31% to 32%. And while the full year EBITDA margin will be softer than this, it is also expected to be stronger than previously communicated.

This is the result of its strategic gross margin improved price yield, cost of goods sold reduction, favourable foreign exchange.

No concrete guidance has been given for the full year, but the CEO appears confident that the positive form can continue.

She said: "Overall, for FY20 we anticipate continued strong revenue growth across our key regions supported by brand and marketing investment in China and the US and the development of both capability and infrastructure to support in-market execution."

"While we have only just begun our journey in both Greater China and the US, the results of strategic focus and investment are starting to come through. Competitive intensity will continue to increase in China and thus far we have been well prepared. Our investments are strategic and designed to build the brand, deepen our capability and create further organisational depth and resilience to thrive in this environment. This is strongly enabled by our deep sense of purpose, the passion that backs that up and importantly, our growth mindset as a team," concluded Ms Hrdlicka

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the week for investors this Friday.

Read more »

Woman thinking in a supermarket.
Dividend Investing

Coles stock vs Woolworths shares: Who had the better dividend this week?

Let's check the receipts on Coles and Woolies this week.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »

ASX board.
ASX Share Market News

Why the ASX 200 is pushing higher as rate hike fears grow

Tech stocks are leading the market rebound today.

Read more »

Small kid giving a thumbs up.
Broker Notes

9 ASX 200 shares with strengthened buy ratings this week

Brokers are positive on Paladin Energy, Coles, WiseTech, Centuria Capital, and other shares.

Read more »